Pregabalin and Zejula drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pregabalin (pregabalin) and Zejula (niraparib tosylate). Common drug interactions include platelet count decreased among females.

The phase IV clinical study analyzes what interactions people have when they take Pregabalin and Zejula. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.

What is Zejula?

Zejula has active ingredients of niraparib tosylate. eHealthMe is studying from 22,014 Zejula users. Check the latest studies of Zejula.

On Jul, 12, 2026

57 people who take Pregabalin and Zejula together, and have interactions are studied.

Pregabalin and Zejula drug interactions.

What are the common drug interactions of Pregabalin and Zejula, by gender? *:

female:

Platelet count decreased
Fatigue (feeling of tiredness)
Hypoaesthesia (reduced sense of touch or sensation)
Pain in extremity
Peripheral swelling
Asthenia (weakness)
White blood cell count decreased
Influenza
Malaise (a feeling of general discomfort or uneasiness)
Adverse drug reaction

male:

n/a

What are the common drug interactions of Pregabalin and Zejula, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Affect lability (emotional incontinence)
Dehydration (dryness resulting from the removal of water)
Depression
Ear infection
Fatigue (feeling of tiredness)
Insomnia (sleeplessness)
Nausea (feeling of having an urge to vomit)
Skin disorder (skin disease)

50-59:

Abdominal pain
Constipation
Diarrhoea
Platelet count decreased
Red blood cell count decreased
Thrombocytopenia (decrease of platelets in blood)
Hypoaesthesia (reduced sense of touch or sensation)
Pain in extremity
Peripheral swelling
Adverse drug reaction

60+:

Dizziness
Fatigue (feeling of tiredness)
Emotional disorder
Eye disorder
Fall
Haemoglobin decreased
Influenza
Insomnia (sleeplessness)
Malaise (a feeling of general discomfort or uneasiness)
Memory impairment

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 26 people, 45.61%
Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 16 people, 28.07%
Fallopian Tube Cancer (cancer of fallopian tube): 15 people, 26.32%
Ovarian Epithelial Cancer (cancer that begins in the cells on the surface of the ovary): 11 people, 19.30%
Neuropathy Peripheral (surface nerve damage): 8 people, 14.04%
Constipation: 8 people, 14.04%
Ovarian Epithelial Cancer Recurrent (reoccurrence of cancer that begins in the cells on the surface of the ovary): 4 people, 7.02%
Heart Rate Irregular: 3 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and Zejula?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously